Literature DB >> 28573541

miR-215 functions as an oncogene in high-grade glioma by regulating retinoblastoma 1.

Xiaofeng Meng1, Baozhong Shi2.   

Abstract

OBJECTIVES: To investigate the roles of miR-215 in high-grade glioma and to clarify the regulation of retinoblastoma 1 (RB1) by miR-215.
RESULTS: miR-215 is frequently up-regulated in high-grade glioma tissues. Increased miR-215 expression is significantly associated with World Health Organization grade (P < 0.01) tumor size (P < 0.05) and poor prognosis (P < 0.01). Over-expression of miR-215 promoted cell proliferation and knockdown of miR-215 inhibited cell proliferation in vitro. RB1 was identified as a direct and functional target of miR-215. RB1 is generally down-regulated in glioma tissues and its expression inversely correlated with miR-215, which is up-regulated in high-grade glioma tissues, and its expression was negatively correlated with miR-215.
CONCLUSIONS: The new miR-215/RB1 axis provides new insights into the molecular mechanism and treatment for glioma.

Entities:  

Keywords:  Glioma; High-grade glioma; Proliferation; Retinoblastoma; Tumors; miR-215

Mesh:

Substances:

Year:  2017        PMID: 28573541     DOI: 10.1007/s10529-017-2373-7

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  7 in total

1.  Down-regulation of miR-215 attenuates lipopolysaccharide-induced inflammatory injury in CCD-18co cells by targeting GDF11 through the TLR4/NF-kB and JNK/p38 signaling pathways.

Authors:  Boyang Sun; Kai Xing; Chen Qi; Ke Yan; Yan Xu
Journal:  Histol Histopathol       Date:  2020-11-04       Impact factor: 2.303

2.  MicroRNA-215-3p Suppresses the Growth, Migration, and Invasion of Colorectal Cancer by Targeting FOXM1.

Authors:  Xiaowei Tang; Xianfeng Shi; Nianfei Wang; Wanren Peng; Zhendong Cheng
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

3.  miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.

Authors:  Jihua Han; Meiyin Zhang; Chunlei Nie; Jinliang Jia; Fengyue Wang; Jiawei Yu; Wen Bi; Bo Liu; Ruinan Sheng; Guoqing He; Lingyu Kong; Lingling Zheng; Rui Pang; Zhaoming Ding; Lili Chen; Qiang Guan; Shangha Pan; Xianzhi Meng; Jin Xu; Lianxin Liu; Jiewu Zhang
Journal:  Cell Death Dis       Date:  2019-02-27       Impact factor: 8.469

4.  ETS1-activated SNHG10 exerts oncogenic functions in glioma via targeting miR-532-3p/FBXL19 axis.

Authors:  Lide Jin; Shengquan Huang; Congjin Guan; Shun Chang
Journal:  Cancer Cell Int       Date:  2020-12-09       Impact factor: 5.722

5.  Overexpression of serum extracellular vesicle microRNA-215-5p is associated with early tumor recurrence and poor prognosis of gastric cancer.

Authors:  Yunfei Zhang; Fengchang Huang; Ning Xu; Jin Wang; Dan Li; Liang Yin
Journal:  Clinics (Sao Paulo)       Date:  2021-05-05       Impact factor: 2.365

6.  MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).

Authors:  Wei Zhang; Mingkai Zhang; Lantao Liu; Dan Jin; Pengyu Wang; Jing Hu
Journal:  Med Sci Monit       Date:  2018-10-07

7.  A five-miRNA panel in plasma was identified for breast cancer diagnosis.

Authors:  Minghui Li; Xuan Zou; Tiansong Xia; Tongshan Wang; Ping Liu; Xin Zhou; Shui Wang; Wei Zhu
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.